We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-3.11%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.4B
AUM Growth
-$526M
Cap. Flow
+$279M
Cap. Flow %
1.3%
Top 10 Hldgs %
19.79%
Holding
3,307
New
142
Increased
1,419
Reduced
1,480
Closed
171

Sector Composition

Rank Sector Weight
1 Technology 10.11%
2 Financials 4.79%
3 Consumer Discretionary 4.07%
4 Healthcare 3.88%
5 Industrials 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPD icon
2626
Rapid7
RPD
$928M
$255K ﹤0.01%
+5,576
New +$257K
EXI icon
2627
iShares Global Industrials ETF
EXI
$1.49B
$254K ﹤0.01%
+2,250
New +$268K
TAK icon
2628
Takeda Pharmaceutical
TAK
$55.6B
$254K ﹤0.01%
16,433
+883
+6% +$13.7K
LTC
2629
LTC Properties
LTC
$2.11B
$253K ﹤0.01%
7,871
-475
-6% -$15.7K
MIY icon
2630
BlackRock MuniYield Michigan Quality Fund
MIY
$362M
$253K ﹤0.01%
25,431
+1,801
+8% +$19.4K
MUE
2631
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
$253K ﹤0.01%
28,821
+221
+0.8% +$2.11K
GPK icon
2632
Graphic Packaging
GPK
$3.51B
$252K ﹤0.01%
11,323
-1,689
-13% -$38.8K
AMJ
2633
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$252K ﹤0.01%
10,216
-4,816
-32% -$115K
GENY
2634
DELISTED
Principal Exchange-Traded Funds Principal Millennial Global Growth ETF
GENY
$252K ﹤0.01%
6,341
-325
-5% -$13.7K
JAZZ icon
2635
Jazz Pharmaceuticals
JAZZ
$16B
$251K ﹤0.01%
1,941
-457
-19% -$60.9K
TXRH icon
2636
Texas Roadhouse
TXRH
$13.6B
$251K ﹤0.01%
2,617
-148
-5% -$15.8K
BL icon
2637
BlackLine
BL
$1.82B
$250K ﹤0.01%
4,500
-377
-8% -$20.7K
FCN icon
2638
FTI Consulting
FCN
$4.22B
$250K ﹤0.01%
1,401
+28
+2% +$5.22K
JHSC icon
2639
John Hancock Multifactor Small Cap ETF
JHSC
$746M
$250K ﹤0.01%
7,786
-577
-7% -$19.4K
PSCX icon
2640
Pacer Swan SOS Conservative January ETF
PSCX
$46.6M
$250K ﹤0.01%
10,842
-3,880
-26% -$90.4K
SFL icon
2641
SFL Corp
SFL
$1.61B
$250K ﹤0.01%
22,457
+1,472
+7% +$15.2K
SKYW icon
2642
Skywest
SKYW
$4.2B
$250K ﹤0.01%
5,970
-2,642
-31% -$111K
BKLC icon
2643
BNY Mellon US Large Cap Core Equity ETF
BKLC
$5.72B
$249K ﹤0.01%
+9,207
New +$257K
BMRN icon
2644
BioMarin Pharmaceuticals
BMRN
$13.3B
$249K ﹤0.01%
2,809
-1,253
-31% -$111K
ECF
2645
Ellsworth Growth & Income Fund
ECF
$178M
$249K ﹤0.01%
30,994
+1,399
+5% +$12K
OSK icon
2646
Oshkosh
OSK
$9.39B
$249K ﹤0.01%
2,607
-7,533
-74% -$730K
TOK icon
2647
iShares MSCI Kokusai Fund
TOK
$258M
$249K ﹤0.01%
2,800
VNQI icon
2648
Vanguard Global ex-US Real Estate ETF
VNQI
$3.52B
$249K ﹤0.01%
6,399
-893
-12% -$36.2K
BIO icon
2649
Bio-Rad Laboratories Class A
BIO
$9.66B
$248K ﹤0.01%
692
-40
-5% -$15.4K
FDUS icon
2650
Fidus Investment
FDUS
$751M
$248K ﹤0.01%
12,894
-732
-5% -$14.4K

Similar funds

Cambridge Investment Research Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Cambridge Investment Research Advisors held 3,307 positions worth $21.4B, down 2.4% from $21.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q3 2023 filing shows 142 new, 1,419 increased, 1,480 reduced and 171 closed positions. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 139,542 shares worth $6.12M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $46.5M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q3 2023 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 139,542 shares worth $6.12M.
  • Cambridge Investment Research Advisors added most to iShares 0-1 Year Treasury Bond ETF in Q3 2023, an estimated $69.3M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $46.5M.
  • Cambridge Investment Research Advisors fully exited Invesco S&P SmallCap Quality ETF in Q3 2023, selling an estimated $4.88M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.4B portfolio in Q3 2023.
  • Cambridge Investment Research Advisors opened 142 new positions and closed 171 in Q3 2023.
  • Cambridge Investment Research Advisors's portfolio value fell 2.4% quarter-over-quarter to $21.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.